JPM23: Califf on accelerated approvals, biotech startups’ looming cliff and an explanation from Editas

JPM23: Califf on accelerated approvals, biotech startups’ looming cliff and an explanation from Editas

Submitted by admin on January 11, 2023 - 12:16pm
Source: 
BioPharma Dive
News Tags: 
JPMHC 2023
FDA
Robert Califf
funding
venture capital
biotech
Headline: 
JPM23: Califf on accelerated approvals, biotech startups’ looming cliff and an explanation from Editas
snippet: 

The FDA head shared advice for drugmakers at the J.P. Morgan Healthcare conference, while VCs cautioned of a coming funding crunch for young biotechs.

Do Not Allow Advertisers to Use My Personal information